COMP <GO>
RLYB vs CRBP // FREE CASH FLOW YIELD
Rallybio Corporation (NASDAQ) VS. Corbus Pharmaceuticals Holdings Inc. (NASDAQ) • 15-METRIC TALLY: RLYB 3
— CRBP 0
■ METRIC PARITY
LAST: $15.54 (+0.84%) • MKT CAP: $83.0M
fcf-yield
—
LAST: $4.22 (0.00%) • MKT CAP: $81.6M
fcf-yield
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RLYB VS. CRBP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RLYB | CRBP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 34.90% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.13 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | RLYB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.4 | 25.6 | +14.84 | RLYB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $83.0M | $81.6M | $1.3M | RLYB | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RLYB REV | CRBP REV | RLYB GROSS % | CRBP GROSS % | RLYB FCF | CRBP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $858.0K | $0 | — | — | -$29.8M | -$64.5M |
| FY 2024 | $636.0K | $0 | — | — | -$49.3M | -$41.8M |
| FY 2023 | $0 | $0 | — | — | -$60.3M | -$36.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RLYB // BETA —
CRBP // BETA —